FDA Marketing Rules Stretch To Drugmakers' Media Pitches

Law360, New York (November 13, 2012, 10:21 PM EST) -- The U.S. Food and Drug Administration recently scolded Cornerstone Therapeutics Inc. for failing to include information about a drug's risks in a letter seeking publicity from media outlets, an unusual warning that shows the agency considers all promotional materials, not just those directed to the public, to be under its purview.

In a letter dated Oct. 31, the FDA's Office of Prescription Drug Promotion told Cornerstone that a pitch letter and press release sent out by the company's public relations firm were false and misleading. The...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.